Maxi-tuss Tr
Product Images NDC 58605-305

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Maxi-tuss Tr (NDC 58605-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mcr American Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Principal Display Panel (473 mL Bottle Label)
This is a drug facts label that contains information about the active ingredients, uses, and warnings of a medication. It is intended to relieve symptoms of respiratory allergies, such as a runny nose, sneezing, itching, and nasal congestion. The medication contains Pseudoephedrine HCI and Triprolidine HCI and is sugar-free, alcohol-free, and dye-free. The label provides dosing instructions for adults and children over 6 years old and cautions against exceeding recommended dosages or mixing with certain medications or substances. It also includes warnings for individuals with specific health conditions and advises against driving or operating machinery while using the medication. Contact a healthcare professional in case of accidental overdose or persistent symptoms.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.